Publications by authors named "Craig Wakeford"

Claim this Profile
K
Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval.
Aliya A Khan, Eric T Rush, Craig Wakeford, Daniel Staub, Maria Luisa Brandi

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis.
Maria Pia Sormani, Robert Wolff, Shona Lang, Steven Duffy, Robert Hyde, Craig Wakeford

Neurol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis.
Gavin Giovannoni, Shona Lang, Robert Wolff, Steven Duffy, Robert Hyde, Craig Wakeford

Neurol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
Christine Poulos, Craig Wakeford, Elizabeth Kinter, Brennan Mange, Thomas Schenk

Mult Scler J Exp Transl Clin· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT).
Sophie Cleanthous, Stefan Cano, Elizabeth Kinter, Patrick Marquis, Jennifer Petrillo, Craig Wakeford

Mult Scler J Exp Transl Clin· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering the economic value of multiple sclerosis therapies.
Tiffany Shih, Craig Wakeford, Dennis Meletiche, Jesse Sussell, Adrienne Chung

Am J Manag Care· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada.
Robert J Petrella, Craig Wakeford

Drug Des Devel Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis